Table 1.
Sociodemographic, drug use, and hepatitis C virus (HCV) characteristics of young opioid users in New York City, 2014–16, N=539
| Sample prevalence Number (Percent) | |
|---|---|
| Sociodemographics | |
| Age (years) | Mean=24.0 (SD=3.1) |
| Sex | |
| Male | 356 (67.7) |
| Female | 170 (31.5) |
| Transgender | 4 (0.8) |
| Race | |
| White | 371 (68.8) |
| Black | 42 (7.8) |
| Asian/Pacific Islander | 7 (1.3) |
| American Indian or Alaska Native | 9 (1.7) |
| Multiracial | 43 (8.0) |
| Missing* | 67 (12.4) |
| Hispanic/Latino | 154 (28.7) |
| Household income growing up (annual) | |
| <=$50,000 | 227 (42.1) |
| $50,001–100,000 | 176 (32.7) |
| >$100,000 | 102 (18.9) |
| Don’t know or missing | 34 (6.3) |
| Education | |
| Did not complete high school | 107 (19.9) |
| High school graduate or GED | 224 (41.6) |
| Some college | 181 (33.6) |
| College graduate or higher | 26 (4.8) |
| Ever homeless | 309 (57.4) |
| Drug use | |
| Lifetime opioid use characteristics | |
| Heroin only | 6 (1.1) |
| Prescription opioids only | 89 (16.5) |
| Heroin and prescription opioids | 444 (82.4) |
| Lifetime drug injection | 353 (65.5) |
| Past 30 day injection (among ever injectors) | 305 (84.4) |
| HCV | |
| Hepatitis C antibody-positive result on OraQuick test | 105 (19.6) |
| Ever previously tested for HCV | 369 (68.6) |
| Positive result on last HCV test (among n=369 previously tested) | 75 (20.3) |
| Concerned about getting HCV (among n=456 who self-reported negative result on last test) | |
| Very/somewhat (vs. not at all) | 304 (66.7) |
| Talked about HCV with drug-using friends | |
| Very often/often/sometimes (vs. rarely/never) | 187 (35.0) |
| Ever learned about HCV from primary doctor or in drug treatment | 378 (70.1) |
| Ever learned about HCV from syringe exchange, harm reduction, other service provider |
247 (45.8) |
| Percent correct on Brief HCV Knowledge Scale | Mean=68.0 (SD=19.3) |
*
Missing values due to race being reported as Hispanic/Latino